On 16 October 2014, the PARITY team hosted an Investigators Meeting as an ancillary event at the Connective Tissue Oncology Society’s Annual Meeting in Berlin, Germany.
While at the meeting, the investigators were provided an update of the trial and discussed the transition from the pilot to the definitive study and international expansion. In addition, the investigators generated discussion on the process of screening patients, the definition of a serious adverse event, the reporting of adverse events, and the inclusion of pediatric patients (ages 12-14) as the trial transitions into the definitive phase.
Thank you to all those who took the time to attend the meeting. We look forward to seeing you at next year’s event!